2015 Q1 Form 10-K Financial Statement
#000114420415011802 Filed on February 25, 2015
Income Statement
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| Revenue | $1.283M | $5.513M | $1.400M |
| YoY Change | -3.65% | 4.43% | -7.89% |
| Cost Of Revenue | $637.3K | $2.569M | $540.0K |
| YoY Change | 3.61% | 17.06% | -20.59% |
| Gross Profit | $645.7K | $2.944M | $860.0K |
| YoY Change | -9.88% | -4.55% | 1.18% |
| Gross Profit Margin | 50.33% | 53.41% | 61.43% |
| Selling, General & Admin | $3.002M | $7.638M | $1.520M |
| YoY Change | 88.44% | 9.04% | -29.63% |
| % of Gross Profit | 464.89% | 259.44% | 176.74% |
| Research & Development | $902.5K | $4.076M | $710.0K |
| YoY Change | 4.49% | 18.55% | 24.56% |
| % of Gross Profit | 139.78% | 138.44% | 82.56% |
| Depreciation & Amortization | $29.14K | $145.1K | $30.00K |
| YoY Change | -2.85% | -3.69% | -25.0% |
| % of Gross Profit | 4.51% | 4.93% | 3.49% |
| Operating Expenses | $3.904M | $11.71M | $2.240M |
| YoY Change | 58.93% | 12.17% | -17.65% |
| Operating Profit | -$3.259M | -$8.770M | -$1.380M |
| YoY Change | 87.25% | 19.18% | -26.2% |
| Interest Expense | $1.190M | $1.050M | -$2.330M |
| YoY Change | 128.85% | -475.0% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$50.00K | $0.00 | |
| YoY Change | -82.76% | ||
| Pretax Income | -$2.070M | -$7.770M | -$3.700M |
| YoY Change | 69.67% | -3.12% | 97.86% |
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | |||
| Net Earnings | -$2.071M | -$7.766M | -$3.700M |
| YoY Change | 69.14% | -3.15% | 97.86% |
| Net Earnings / Revenue | -161.44% | -140.88% | -264.29% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$69.00M | -$388.5M | -$370.0M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 8.153M shares | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $6.400M | $9.220M | $9.200M |
| YoY Change | -15.57% | 0.22% | 5.75% |
| Cash & Equivalents | $6.403M | $9.220M | $9.196M |
| Short-Term Investments | |||
| Other Short-Term Assets | $260.0K | $610.0K | $420.0K |
| YoY Change | -45.83% | 45.24% | -10.64% |
| Inventory | $635.2K | $680.0K | $563.0K |
| Prepaid Expenses | |||
| Receivables | $921.6K | $580.0K | $390.9K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $8.223M | $11.09M | $10.57M |
| YoY Change | -11.17% | 4.92% | -0.06% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $539.7K | $310.0K | $229.3K |
| YoY Change | 171.95% | 34.78% | -21.98% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $370.0K | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Total Long-Term Assets | $908.1K | $310.0K | $230.2K |
| YoY Change | 355.56% | 34.78% | -24.36% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $8.223M | $11.09M | $10.57M |
| Total Long-Term Assets | $908.1K | $310.0K | $230.2K |
| Total Assets | $9.131M | $11.40M | $10.80M |
| YoY Change | -3.43% | 5.56% | -0.74% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $916.5K | $520.0K | $322.9K |
| YoY Change | 58.57% | 62.5% | 25.46% |
| Accrued Expenses | $1.286M | $2.150M | $870.2K |
| YoY Change | 62.47% | 70.63% | -8.29% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | ||
| YoY Change | -100.0% | ||
| Total Short-Term Liabilities | $3.319M | $2.700M | $1.648M |
| YoY Change | 68.49% | 63.64% | -17.83% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $4.130M | $5.320M | $1.950M |
| YoY Change | 186.81% | 172.82% | 2685.71% |
| Total Long-Term Liabilities | $4.130M | $5.320M | $1.950M |
| YoY Change | 186.81% | 172.82% | 2685.71% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.319M | $2.700M | $1.648M |
| Total Long-Term Liabilities | $4.130M | $5.320M | $1.950M |
| Total Liabilities | $7.449M | $8.020M | $3.602M |
| YoY Change | 118.53% | 122.78% | 73.41% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$156.4M | -$146.6M | |
| YoY Change | 5.83% | 5.79% | |
| Common Stock | $852.00 | $595.00 | |
| YoY Change | 43.19% | 178.04% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $1.682M | $3.390M | $7.195M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $9.131M | $11.40M | $10.80M |
| YoY Change | -3.43% | 5.56% | -0.74% |
Cashflow Statement
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$2.071M | -$7.766M | -$3.700M |
| YoY Change | 69.14% | -3.15% | 97.86% |
| Depreciation, Depletion And Amortization | $29.14K | $145.1K | $30.00K |
| YoY Change | -2.85% | -3.69% | -25.0% |
| Cash From Operating Activities | -$2.640M | -$7.680M | -$1.220M |
| YoY Change | 64.17% | 17.16% | -44.8% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $175.2K | $227.3K | -$60.00K |
| YoY Change | 4157.13% | 164.07% | 100.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $0.00 | |
| YoY Change | |||
| Cash From Investing Activities | -$180.0K | -$230.0K | -$60.00K |
| YoY Change | 4274.24% | 167.2% | 100.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 7.930M | 2.640M | |
| YoY Change | 11.11% | ||
| NET CHANGE | |||
| Cash From Operating Activities | -2.640M | -7.680M | -1.220M |
| Cash From Investing Activities | -180.0K | -230.0K | -60.00K |
| Cash From Financing Activities | 7.930M | 2.640M | |
| Net Change In Cash | -2.820M | 20.00K | 1.360M |
| YoY Change | 74.91% | -95.97% | -160.71% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$2.640M | -$7.680M | -$1.220M |
| Capital Expenditures | $175.2K | $227.3K | -$60.00K |
| Free Cash Flow | -$2.815M | -$7.907M | -$1.160M |
| YoY Change | 74.62% | 19.07% | -46.79% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <h2 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: bold 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> </h2> <h3 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 24px; PADDING-RIGHT: 0pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> Use of Estimates and Assumptions</h3> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances and regularly assesses these estimates, but actual results could differ materially from these estimates. Effects of changes in estimates are recorded in the period in which they occur.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9221985 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
390922 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
563036 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
416816 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
10566527 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9195753 | USD |
| CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11090125 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
229313 | USD |
| CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
815 | USD |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2862094 | shares |
| CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-5.22 | |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.07 | |
| CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1918723 | shares |
| CY2014Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
157764598 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-154378302 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3387115 | USD |
| CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11402230 | USD |
| CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
827244 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2239511 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3854221 | shares |
| CY2012 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
0 | USD |
| CY2013 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
-766872 | USD |
| CY2014 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
-2955668 | USD |
| CY2012 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-10007553 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8786009 | USD |
| CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-10721890 | USD |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.54 | |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
6973977 | shares |
| CY2013Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
205320 | USD |
| CY2014Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
209426 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
357716 | USD |
| CY2014Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
470314 | USD |
| CY2012Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
0 | USD |
| CY2013Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
110608 | USD |
| CY2013 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
532115 | USD |
| CY2014 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
302758 | USD |
| CY2013 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
421507 | USD |
| CY2014 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
264445 | USD |
| CY2014Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
148921 | USD |
| CY2013Q4 | nuro |
Technology Fees
TechnologyFees
|
450000 | USD |
| CY2014Q4 | nuro |
Technology Fees
TechnologyFees
|
450000 | USD |
| CY2013Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
263642 | USD |
| CY2014Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
257024 | USD |
| CY2013Q4 | nuro |
Clinical Study Obligations
ClinicalStudyObligations
|
51424 | USD |
| CY2014Q4 | nuro |
Clinical Study Obligations
ClinicalStudyObligations
|
74000 | USD |
| CY2013Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
32688 | USD |
| CY2014Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
34206 | USD |
| CY2013Q4 | nuro |
Accrued Personnel Related Obligations
AccruedPersonnelRelatedObligations
|
12322 | USD |
| CY2014Q4 | nuro |
Accrued Personnel Related Obligations
AccruedPersonnelRelatedObligations
|
37761 | USD |
| CY2013Q4 | nuro |
Accrued Federal Excise Tax
AccruedFederalExciseTax
|
24600 | USD |
| CY2014Q4 | nuro |
Accrued Federal Excise Tax
AccruedFederalExciseTax
|
25989 | USD |
| CY2013Q4 | nuro |
Accrued Consulting Fees
AccruedConsultingFees
|
0 | USD |
| CY2014Q4 | nuro |
Accrued Consulting Fees
AccruedConsultingFees
|
173759 | USD |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
35520 | USD |
| CY2014Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
212137 | USD |
| CY2013Q2 | us-gaap |
Lease Expiration Date1
LeaseExpirationDate1
|
2015-03-31 | |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10007553 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8019137 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7766222 | USD |
| CY2012 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
297097 | USD |
| CY2013 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
150663 | USD |
| CY2014 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
145100 | USD |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
319368 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
245843 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
289873 | USD |
| CY2013Q4 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
1938603 | USD |
| CY2014Q4 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
5307332 | USD |
| CY2014Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
2500000 | USD |
| CY2014 | us-gaap |
Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
|
2016-01-15 | |
| CY2013Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.00 | |
| CY2014Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.04 | |
| CY2012 | us-gaap |
Revenues
Revenues
|
7575289 | USD |
| CY2014Q4 | nuro |
Restricted Cash Collateral Letters Of Credit
RestrictedCashCollateralLettersOfCredit
|
451731 | USD |
| CY2014Q4 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
2000000 | USD |
| CY2013Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
4500000 | USD |
| CY2014Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7900000 | USD |
| CY2013Q2 | nuro |
Class Of Warrant Or Right Exercisable Period
ClassOfWarrantOrRightExercisablePeriod
|
P5Y | |
| CY2013Q2 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
248147 | shares |
| CY2014Q2 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
664600 | shares |
| CY2013Q2 | us-gaap |
Share Price
SharePrice
|
2.095 | |
| CY2013 | us-gaap |
Revenues
Revenues
|
5278806 | USD |
| CY2014 | us-gaap |
Revenues
Revenues
|
5512764 | USD |
| CY2012 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
3588806 | USD |
| CY2013 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2194259 | USD |
| CY2014 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2568602 | USD |
| CY2012 | us-gaap |
Gross Profit
GrossProfit
|
3986483 | USD |
| CY2013 | us-gaap |
Gross Profit
GrossProfit
|
3084547 | USD |
| CY2014 | us-gaap |
Gross Profit
GrossProfit
|
2944162 | USD |
| CY2014Q2 | us-gaap |
Share Price
SharePrice
|
2.04 | |
| CY2014Q4 | nuro |
Preferred Stock Stated Value Per Share
PreferredStockStatedValuePerShare
|
1000 | |
| CY2013Q2 | nuro |
Gross Proceeds From Issuance Or Sale Of Equity
GrossProceedsFromIssuanceOrSaleOfEquity
|
5000000 | USD |
| CY2014Q2 | nuro |
Gross Proceeds From Issuance Or Sale Of Equity
GrossProceedsFromIssuanceOrSaleOfEquity
|
8000000 | USD |
| CY2014Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
3921569 | shares |
| CY2014Q1 | nuro |
Closing Price Of Shares
ClosingPriceOfShares
|
2.45 | |
| CY2013Q2 | nuro |
Closing Price Of Shares
ClosingPriceOfShares
|
2.39 | |
| CY2013 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
5666 | USD |
| CY2014 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
4606 | USD |
| CY2012 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
0 | USD |
| CY2012 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2013 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
289657 | USD |
| CY2014 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1050095 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5945581 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
8152746 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5945581 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
8152746 | shares |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
3926600 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
4107478 | USD |
| CY2013Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
3926600 | USD |
| CY2014Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
4107478 | USD |
| CY2013Q4 | nuro |
Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
|
1938603 | USD |
| CY2014Q4 | nuro |
Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
|
5307332 | USD |
| CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3545790 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3438218 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4075976 | USD |
| CY2012 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
5727482 | USD |
| CY2013 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2779695 | USD |
| CY2014 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2913112 | USD |
| CY2012 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4735238 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4225474 | USD |
| CY2012 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
234848 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4725123 | USD |
| CY2012 | us-gaap |
Operating Expenses
OperatingExpenses
|
14008510 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
10443387 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
11714211 | USD |
| CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10022027 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7358840 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8770049 | USD |
| CY2012 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
14474 | USD |
| CY2013 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
151558 | USD |
| CY2014 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
| CY2012 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
0 | USD |
| CY2013 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-376306 | USD |
| CY2014 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-50874 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-343267 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-175529 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
189318 | USD |
| CY2012 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-694327 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-119932 | USD |
| CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
116704 | USD |
| CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
76880 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-52748 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
195454 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-371854 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
65535 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
199975 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-530141 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-54635 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
998434 | USD |
| CY2012 | nuro |
Increase Decrease In Deferred Revenue Deferred Costs And Other Liabilities
IncreaseDecreaseInDeferredRevenueDeferredCostsAndOtherLiabilities
|
-78046 | USD |
| CY2013 | nuro |
Increase Decrease In Deferred Revenue Deferred Costs And Other Liabilities
IncreaseDecreaseInDeferredRevenueDeferredCostsAndOtherLiabilities
|
-108907 | USD |
| CY2014 | nuro |
Increase Decrease In Deferred Revenue Deferred Costs And Other Liabilities
IncreaseDecreaseInDeferredRevenueDeferredCostsAndOtherLiabilities
|
-44956 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-9175567 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-6554908 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-7678493 | USD |
| CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
107465 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
86079 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
122035 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7482884 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7155191 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7932033 | USD |
| CY2013 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
17929 | USD |
| CY2014 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
0 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7462564 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7137262 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7932033 | USD |
| CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1590968 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
496275 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
26232 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10290446 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8699478 | USD |
| CY2012 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
0 | USD |
| CY2013 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-285295 | USD |
| CY2014 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-104405 | USD |
| CY2012 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
0 | USD |
| CY2013 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
4011205 | USD |
| CY2014 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
4418824 | USD |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2014Q2 | dei |
Entity Public Float
EntityPublicFloat
|
12833181 | USD |
| CY2014 | dei |
Trading Symbol
TradingSymbol
|
NURO | |
| CY2015Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
8152746 | shares |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11088521 | USD |
| CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
319368 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
245843 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
289873 | USD |
| CY2012 | nuro |
Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
|
7377048 | USD |
| CY2012 | nuro |
Stock Issued During Period Values Redemption Of Warrants
StockIssuedDuringPeriodValuesRedemptionOfWarrants
|
0 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
23038 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
26285 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
24137 | USD |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-12-31 | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
NeuroMetrix, Inc. | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001289850 | |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2012 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
0 | USD |
| CY2013 | nuro |
Stock Issued During Period Value Securities Purchase Agreement
StockIssuedDuringPeriodValueSecuritiesPurchaseAgreement
|
876786 | USD |
| CY2014 | nuro |
Stock Issued During Period Value Securities Purchase Agreement
StockIssuedDuringPeriodValueSecuritiesPurchaseAgreement
|
3539947 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
| CY2013 | nuro |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
2617222 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2362259 | USD |
| CY2013 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
285295 | USD |
| CY2014 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
104405 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8800422 | USD |
| CY2012 | us-gaap |
Stock Issued1
StockIssued1
|
127885 | USD |
| CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
| CY2014 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
| CY2012 | nuro |
Warrants Issued In Public Offering
WarrantsIssuedInPublicOffering
|
2373267 | USD |
| CY2013 | nuro |
Warrants Issued In Public Offering
WarrantsIssuedInPublicOffering
|
0 | USD |
| CY2014 | nuro |
Warrants Issued In Public Offering
WarrantsIssuedInPublicOffering
|
0 | USD |
| CY2012 | nuro |
Reclassification Of Warrant Liability To Additional Paid In Capital Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapitalUponExerciseOfWarrants
|
0 | USD |
| CY2013 | nuro |
Reclassification Of Warrant Liability To Additional Paid In Capital Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapitalUponExerciseOfWarrants
|
2362259 | USD |
| CY2014 | nuro |
Reclassification Of Warrant Liability To Additional Paid In Capital Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapitalUponExerciseOfWarrants
|
0 | USD |
| CY2012 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-229500 | USD |
| CY2013 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2014Q2 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
664600 | shares |
| CY2014Q2 | us-gaap |
Share Price
SharePrice
|
2.04 | |
| CY2014Q2 | nuro |
Gross Proceeds From Issuance Or Sale Of Equity
GrossProceedsFromIssuanceOrSaleOfEquity
|
8000000 | USD |
| CY2014 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left"></div> <h3 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 24px; PADDING-RIGHT: 0pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> Concentrations of Credit Risk</h3> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents in bank deposit accounts and trade receivables. The Company invests its funds in highly rated institutions and limits its investment in any individual account so that they do not exceed FDIC limits. The Company has not experienced significant losses related to cash and cash equivalents and does not believe it is exposed to any significant credit risks relating to its cash and cash equivalents.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">At December 31, 2014, one customer accounted for 30% of accounts receivable. For the year ended December 31, 2014 one customer accounted for more than 10% of revenue. For the years ended December 31, 2013, and 2012, no single customer accounted for more than 10% of revenue.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The Company relies on in-house assembly and three third-party manufacturers to manufacture the major portion of its current products and product components. The disruption or termination of the supply of these products or a significant increase in the cost of these products from these sources could have an adverse effect on the Company’s business, financial position, and results of operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
4719 | USD |
| CY2014Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1784 | USD |
| CY2012 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
242000 | USD |
| CY2013 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
151000 | USD |
| CY2014 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
481000 | USD |
| CY2012 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.07 | pure |
| CY2013 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.16 | pure |
| CY2014 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.19 | pure |
| CY2012 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
319000 | USD |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
246000 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
-4.75 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
5.49 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.7 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.7 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.7 | pure |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
310146 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
537300 | shares |
| CY2014 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
84554 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
1125 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
761767 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
691404 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
146646 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
13.20 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.82 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
10.30 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
249.68 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.15 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
19.10 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y1M24D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P9Y1M10D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y9M29D | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
109460 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
100761 | USD |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
21586 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
17476 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
0 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
16644 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
0 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
832 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
4.62 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | |
| CY2012 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
37167 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
2000 | shares |
| CY2012 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
23000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
26000 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
24000 | USD |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
290000 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
0 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.90 | |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
700000 | shares |
| CY2014Q4 | nuro |
Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Price Per Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAveragePricePerShares
|
0.87 | |
| CY2012 | nuro |
Number Of Shares Authorized To With Holding In Lieu Of Paying With Holding Taxes
NumberOfSharesAuthorizedToWithHoldingInLieuOfPayingWithHoldingTaxes
|
721 | shares |
| CY2013 | nuro |
Number Of Shares Authorized To With Holding In Lieu Of Paying With Holding Taxes
NumberOfSharesAuthorizedToWithHoldingInLieuOfPayingWithHoldingTaxes
|
4214 | shares |
| CY2014 | nuro |
Number Of Shares Authorized To With Holding In Lieu Of Paying With Holding Taxes
NumberOfSharesAuthorizedToWithHoldingInLieuOfPayingWithHoldingTaxes
|
0 | shares |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.67 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.02 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.06 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
| CY2014Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
538188 | USD |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
615953 | shares |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
594906 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
515722 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
3766621 | USD |
| CY2012 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
709164 | USD |
| CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
635004 | USD |
| CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
638679 | USD |
| CY2014Q4 | us-gaap |
Purchase Obligation
PurchaseObligation
|
76338 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.017 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.010 | pure |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
145100 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
32253602 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
35449695 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1735265 | USD |
| CY2012 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3180495 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2827566 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2951182 | USD |
| CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2516046 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.035 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.048 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.070 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.008 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.034 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.036 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.367 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.371 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.347 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2012 | us-gaap |
Depreciation
Depreciation
|
239168 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
150663 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1855586 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
493075 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
657132 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
565077 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
590006 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1061212 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
13506 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
36108231 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
38565925 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
36108231 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
38565925 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
7348998 | shares |
| CY2014Q4 | nuro |
Income Tax Expense Benefit Attributable To Tax Credit Carry Forwards
IncomeTaxExpenseBenefitAttributableToTaxCreditCarryForwards
|
71000 | USD |
| CY2014Q4 | nuro |
Income Tax Expense Benefit Attributable To Net Operating Loss Carry Forward
IncomeTaxExpenseBenefitAttributableToNetOperatingLossCarryForward
|
3900000 | USD |
| CY2014 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y3M18D | |
| CY2014Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7900000 | USD |
| CY2014Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
3921569 | shares |
| CY2014Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.04 | |
| CY2014Q2 | nuro |
Class Of Warrant Or Right Exercisable Period
ClassOfWarrantOrRightExercisablePeriod
|
P5Y | |
| CY2014 | nuro |
Entity Date Of Incorporation
EntityDateOfIncorporation
|
1996-06 | |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
35895 | USD |
| CY2014Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
39966 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
527693 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
539665 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
544285 | USD |
| CY2014Q4 | nuro |
Operating Leases Future Minimum Payments Due In Six Years
OperatingLeasesFutureMinimumPaymentsDueInSixYears
|
475408 | USD |
| CY2014Q4 | nuro |
Operating Leases Future Minimum Payments Due In Seven Years
OperatingLeasesFutureMinimumPaymentsDueInSevenYears
|
487380 | USD |
| CY2014Q4 | nuro |
Operating Leases Future Minimum Payments Due In Eight Years
OperatingLeasesFutureMinimumPaymentsDueInEightYears
|
81562 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0.109 | pure |
